Phase I/II trial of Reolysin (reovirus) in combination with carboplatin and paclitaxel in patients with advanced solid tumours (phase 1) and head and neck cancer (phase II).

Trial Profile

Phase I/II trial of Reolysin (reovirus) in combination with carboplatin and paclitaxel in patients with advanced solid tumours (phase 1) and head and neck cancer (phase II).

Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Aug 2014

At a glance

  • Drugs Pelareorep (Primary) ; Carboplatin; Paclitaxel
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Oncolytics Biotech
  • Most Recent Events

    • 20 Apr 2012 Status changed from active, no longer recruiting to completed based on presented results.
    • 07 Jun 2010 Updated survival results presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO-2010)
    • 21 May 2010 Results will be presented at ASCO 2010, according to an Oncolytics Biotech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top